Classification of exon 18 linked variants of VWF gene in von Willebrand disease

International Journal of Molecular Epidemiology and Genetics

Volumn 3, Issue 1, 2012, Pages 77-83

  Shahbazi, Shirin ^a   Alavi, Sara ^b   Mahdian, Reza ^b  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b PASTEUR INSTITUTE OF IRAN   (Iran)

Author keywords

Allele frequency; Genetic polymorphisms; von willebrand disease; VWF gene

Indexed keywords

VON WILLEBRAND FACTOR;

ALLELE; ARTICLE; EXON; GENE FREQUENCY; GENE MUTATION; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HUMAN; SINGLE NUCLEOTIDE POLYMORPHISM; VON WILLEBRAND DISEASE;

EID: 84858730805     PISSN: None     EISSN: 19481756     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Denis CV. Molecular and cellular biology of von willebrand factor. Int J Hematol 2002; 75: 3-8.
2. Sadler JE, Budde U, Eikenboom JC, Favaloro EJ, Hill FG, Holmberg L, Ingerslev J, Lee CA, Lillicrap D, Mannucci PM, Mazurier C, Meyer D, Nichols WL, Nishino M, Peake IR, Rodeghiero F, Schneppenheim R, Ruggeri ZM, Srivastava A, Montgomery RR, Federici AB. Update on the pathophysiology and classification of von willebrand disease: A report of the subcommittee on von willebrand factor. J Thromb Haemost 2006; 4: 2103-2114.
3. Mannucci PM, Bloom AL, Larrieu MJ, Nilsson IM, West RR. Atherosclerosis and von willebrand factor. I. Prevalence of severe von willebrand's disease in western europe and israel. Br J Haematol 1984; 57: 163-169.
4. Mancuso DJ, Tuley EA, Westfield LA, Worrall NK, Shelton-Inloes BB, Sorace JM, Alevy YG, Sadler JE. Structure of the gene for human von willebrand factor. J Biol Chem 1989; 264: 19514-19527.
5. Ginsburg D, Handin RI, Bonthron DT, Donlon TA, Bruns GA, Latt SA, Orkin SH. Human von willebrand factor (vwf): Isolation of complementary DNA (cdna) clones and chromosomal localization. Science 1985; 228: 1401-1406.
6. Verweij CL, de Vries CJ, Distel B, van Zonneveld AJ, van Kessel AG, van Mourik JA, Pannekoek H. Construction of cdna coding for human von willebrand factor using antibody probes for colony-screening and mapping of the chromosomal gene. Nucleic Acids Res 1985; 13: 4699-4717.
7. Girma JP, Meyer D, Verweij CL, Pannekoek H, Sixma JJ. Structure-function relationship of human von willebrand factor. Blood 1987; 70: 605-611.
8. Foster PA, Fulcher CA, Marti T, Titani K, Zimmerman TS. A major factor viii binding domain resides within the amino-terminal 272 amino acid residues of von willebrand factor. J Biol Chem 1987; 262: 8443-8446.
9. Takahashi Y, Kalafatis M, Girma JP, Sewerin K, Andersson LO, Meyer D. Localization of a factor viii binding domain on a 34 kilodalton fragment of the n-terminal portion of von willebrand factor. Blood 1987; 70: 1679-1682.
10. Tosetto A, Rodeghiero F, Castaman G, Goodeve A, Federici AB, Batlle J, Meyer D, Fressinaud E, Mazurier C, Goudemand J, Eikenboom J, Schneppenheim R, Budde U, Ingerslev J, Vorlova Z, Habart D, Holmberg L, Lethagen S, Pasi J, Hill F, Peake I. A quantitative analysis of bleeding symptoms in type 1 von willebrand disease: Results from a multicenter european study (mcmdm-1 vwd). J Thromb Haemost 2006; 4: 766-773.
11. Shahbazi S, Mahdian R, Ala FA, Lavergne JM, Denis CV, Christophe OD. Molecular characterization of iranian patients with type 3 von willebrand disease. Haemophilia 2009; 15: 1058-1064.
12. Enayat MS, Guilliatt AM, Short PE, RastegarLari G, Jazebi M, Ravonbod S, Ala F, Chapman OG, Hill FG. A novel alanine or threonine 789 to proline mutation causing type 2n von willebrand's disease when inherited homozygously or heterozygously with arginine 854 to glutamine mutation. Haemophilia 2010; 16: 966-969.
13. Kunkel GR, Graham JB, Fowlkes DM, Lord ST. Rsai polymorphism in von willebrand factor (vwf) at codon 789. Nucleic Acids Res 1990; 18: 4961.
14. Cumming A, Grundy P, Keeney S, Lester W, Enayat S, Guilliatt A, Bowen D, Pasi J, Keeling D, Hill F, Bolton-Maggs PH, Hay C, Collins P. An investigation of the von willebrand factor genotype in uk patients diagnosed to have type 1 von willebrand disease. Thromb Haemost 2006; 96: 630-641.
15. Ahmad F, Kannan M, Biswas A, Saxena R. Impact of 789ala/ala genotype on quantitative type of von willebrand disease. Ann Hematol 2009; 88: 479-483.
16. Wagner DD, Fay PJ, Sporn LA, Sinha S, Lawrence SO, Marder VJ. Divergent fates of von willebrand factor and its propolypeptide (von willebrand antigen ii) after secretion from endothelial cells. Proc Natl Acad Sci USA 1987; 84: 1955-1959.
17. Burgess TL, Kelly RB. Constitutive and regulated secretion of proteins. Annu Rev Cell Biol 1987; 3: 243-293.
18. Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ Jr, Montgomery RR. The effect of abo blood group on the diagnosis of von willebrand disease. Blood 1987; 69: 1691-1695.
19. de Lange M, Snieder H, Ariens RA, Spector TD, Grant PJ. The genetics of haemostasis: A twin study. Lancet 2001; 357: 101-105.
20. Gallinaro L, Cattini MG, Sztukowska M, Padrini R, Sartorello F, Pontara E, Bertomoro A, Daidone V, Pagnan A, Casonato A. A shorter von willebrand factor survival in o blood group subjects explains how abo determinants influence plasma von willebrand factor. Blood 2008; 111: 3540-3545.
21. Lacquemant C, Gaucher C, Delorme C, Chatellier G, Gallois Y, Rodier M, Passa P, Balkau B, Mazurier C, Marre M, Froguel P. Association between high von willebrand factor levels and the thr789ala vwf gene polymorphism but not with nephropathy in type i diabetes. The genediab study group and the desir study group. Kidney Int 2000; 57: 1437-1443.
22. Klemm T, Mehnert AK, Siegemund A, Wiesner TD, Gelbrich G, Bluher M, Paschke R. Impact of the thr789ala variant of the von willebrand factor levels, on ristocetin co-factor and collagen binding capacity and its association with coronary heart disease in patients with diabetes mellitus type 2. Exp Clin Endocrinol Diabetes 2005; 113: 568-572.
23. Smith NL, Chen MH, Dehghan A, Strachan DP, Basu S, Soranzo N, Hayward C, Rudan I, Sabater-Lleal M, Bis JC, de Maat MP, Rumley A, Kong X, Yang Q, Williams FM, Vitart V, Campbell H, Malarstig A, Wiggins KL, Van Duijn CM, McArdle WL, Pankow JS, Johnson AD, Silveira A, McKnight B, Uitterlinden AG, Aleksic N, Meigs JB, Peters A, Koenig W, Cushman M, Kathiresan S, Rotter JI, Bovill EG, Hofman A, Boerwinkle E, Tofler GH, Peden JF, Psaty BM, Leebeek F, Folsom AR, Larson MG, Spector TD, Wright AF, Wilson JF, Hamsten A, Lumley T, Witteman JC, Tang W, O'Donnell CJ. Novel associations of multiple genetic loci with plasma levels of factor vii, factor viii, and von willebrand factor: The charge (cohorts for heart and aging research in genome epidemiology) consortium. Circulation 2010; 121: 1382-1392.
24. van Schie MC, de Maat MP, Isaacs A, van Duijn CM, Deckers JW, Dippel DW, Leebeek FW. Variation in the von willebrand factor gene is associated with von willebrand factor levels and with the risk for cardiovascular disease. Blood 2011; 117: 1393-1399.
25. Zabaneh D, Gaunt TR, Kumari M, Drenos F, Shah S, Berry D, Power C, Hypponen E, Shah T, Palmen J, Pallas J, Talmud PJ, Casas JP, Sofat R, Lowe G, Rumley A, Morris RW, Whincup PH, Rodriguez S, Ebrahim S, Marmot MG, Smith GD, Lawlor DA, Kivimaki M, Whittaker J, Hingorani AD, Day IN, Humphries SE. Genetic variants associated with von willebrand factor levels in healthy men and women identified using the humancvd beadchip. Ann Hum Genet 2011; 75: 456-467.
26. Smith NL, Rice KM, Bovill EG, Cushman M, Bis JC, McKnight B, Lumley T, Glazer NL, van Hylckama Vlieg A, Tang W, Dehghan A, Strachan DP, O'Donnell CJ, Rotter JI, Heckbert SR, Psaty BM, Rosendaal FR. Genetic variation associated with plasma von willebrand factor levels and the risk of incident venous thrombosis. Blood 2011; 117: 6007-6011.
27. Campos M, Sun W, Yu F, Barbalic M, Tang W, Chambless LE, Wu KK, Ballantyne C, Folsom AR, Boerwinkle E, Dong JF. Genetic determinants of plasma von willebrand factor antigen levels: A target gene snp and haplotype analysis of aric cohort. Blood 2011; 117: 5224-5230